CS18: a new drug that can potentially overcome cancer drug resistance
CS18 is a candidate for further development as a drug that could become part of combination treatments to prevent or overcome cancer drug resistance.
Read More
From The Labs
Stay in the know about the scientific research conducted at Baylor College of Medicine with From the Labs, the spotlight for the newest and most interesting research findings from the bench at the College.
BCM-led team awarded inaugural Burroughs Wellcome Fund Climate Health Center of Excellence Grant to advance climate and health research
The $10 million award will be used to build FORECAST, an integrated system to study how a rapidly changing environment and weather drive the emergence and expansion of deadly pathogens in human populations.
Read More
Tractor-Mix helps scientists uncover disease-linked genes that traditional methods can miss
A new computational method enables scientists to more accurately identify genetic changes linked to disease.
Read More
Elephant vaccine shows first signs of protection against deadly virus
The studies represent a significant step toward protecting vulnerable elephant calves from a disease that has challenged the elephant community for decades.
Read More
A closer look at brain tissue vulnerability in neurological disease
New evidence explains differences in brain tissue vulnerability using animal models of human spinocerebellar ataxia type 1.
Read More
New imaging tools to listen in on the brain’s ‘electrical whispers’
These biosensors make previously undetectable signals visible, opening new possibilities for studying how neural circuits process information.
Read More
Researchers uncovered a novel pathway that causes epilepsy
The findings also provide a new approach to improve the diagnosis of epilepsy, for which a genetic cause cannot be found in about 50 % of individuals with the condition.
Read More
Turning the tables on chemotherapy resistance: LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer
The team identified underlying molecular mechanisms of platinum resistance that they neutralized with combinations of available drugs to reduce tumor growth in animal models.
Read More
BCM, TCH research recognized with prestigious Burroughs Wellcome Fund award
The award supports research on the molecular and cellular mechanisms involved with rare genetic disorders that affect immune defense.
Read More
TRISH calls for innovations to better understand venous thromboembolism in space
The Translational Research Institute for Space Health is seeking proposals to address venous thromboembolism, a critical risk to human health during spaceflight.
Read More